Metropolis Healthcare Limited Stock Current Valuation
| METROPOLIS | 1,579 20.95 1.31% |
Valuation analysis of Metropolis Healthcare helps investors to measure Metropolis Healthcare's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. At this time, Metropolis Healthcare's Cash is very stable compared to the past year. As of the 26th of March 2025, Cash And Short Term Investments is likely to grow to about 1.9 B, while Cash And Equivalents is likely to drop about 217.2 M. Fundamental drivers impacting Metropolis Healthcare's valuation include:
Price Book 6.9893 | Enterprise Value 82.7 B | Enterprise Value Ebitda 24.9549 | Price Sales 6.2801 | Forward PE 37.1747 |
Overvalued
Today
Please note that Metropolis Healthcare's price fluctuation is very steady at this time. Calculation of the real value of Metropolis Healthcare is based on 3 months time horizon. Increasing Metropolis Healthcare's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Metropolis Healthcare is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Metropolis Stock. However, Metropolis Healthcare's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1579.05 | Real 1432.41 | Hype 1597.92 | Naive 1601.71 |
The intrinsic value of Metropolis Healthcare's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Metropolis Healthcare's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Metropolis Healthcare Limited helps investors to forecast how Metropolis stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Metropolis Healthcare more accurately as focusing exclusively on Metropolis Healthcare's fundamentals will not take into account other important factors: Metropolis Healthcare Limited Company Current Valuation Analysis
Metropolis Healthcare's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Metropolis Healthcare Current Valuation | 82.69 B |
Most of Metropolis Healthcare's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Metropolis Healthcare Limited is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Metropolis Healthcare Limited has a Current Valuation of 82.69 B. This is much higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The current valuation for all India stocks is significantly lower than that of the firm.
Metropolis Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Metropolis Healthcare's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Metropolis Healthcare could also be used in its relative valuation, which is a method of valuing Metropolis Healthcare by comparing valuation metrics of similar companies.Metropolis Healthcare is currently under evaluation in current valuation category among its peers.
Metropolis Fundamentals
| Return On Equity | 0.13 | ||||
| Return On Asset | 0.0863 | ||||
| Profit Margin | 0.12 % | ||||
| Operating Margin | 0.14 % | ||||
| Current Valuation | 82.69 B | ||||
| Shares Outstanding | 51.28 M | ||||
| Shares Owned By Insiders | 49.30 % | ||||
| Shares Owned By Institutions | 45.98 % | ||||
| Price To Book | 6.99 X | ||||
| Price To Sales | 6.28 X | ||||
| Revenue | 12.08 B | ||||
| Gross Profit | 10.25 B | ||||
| EBITDA | 2.97 B | ||||
| Net Income | 1.28 B | ||||
| Cash And Equivalents | 198.82 M | ||||
| Total Debt | 1.97 B | ||||
| Book Value Per Share | 231.09 X | ||||
| Cash Flow From Operations | 2.64 B | ||||
| Earnings Per Share | 29.53 X | ||||
| Target Price | 2095.82 | ||||
| Number Of Employees | 4.31 K | ||||
| Beta | 0.41 | ||||
| Market Capitalization | 82.7 B | ||||
| Total Asset | 15.55 B | ||||
| Retained Earnings | 8.88 B | ||||
| Working Capital | 699.55 M | ||||
| Net Asset | 15.55 B |
About Metropolis Healthcare Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Metropolis Healthcare Limited's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Metropolis Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Metropolis Healthcare Limited based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Other Information on Investing in Metropolis Stock
Metropolis Healthcare financial ratios help investors to determine whether Metropolis Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Metropolis with respect to the benefits of owning Metropolis Healthcare security.